Table 1 Characteristics of patients with HA20
From: Expanding the spectrum of A20 haploinsufficiency in two Chinese families: cases report
Patient no | Family | Gender | Current age | Age at onset | Previous diagnosis | Current diagnosis | Previous treatment | Current treatment |
|---|---|---|---|---|---|---|---|---|
1 | Family 1 | F | 14.1 years | 7.0 years | liver fibrosis Hypothyroidism SLE Lupus nephritis | HA20 | Prednisolone MMF Sodium levothyroxine HCQ | Prednisolone MMF Sodium levothyroxine HCQ Etanercept |
2 | Family 1 | M | 5.1 years | 2.5 years | Crohn’s disease IBD-RA | HA20 | Prednisolone 5-AminoSalicylicAcid MTX | Prednisolone 5-AminoSalicylicAcid MTX Etanercept |
3 | Family 1 | M | 38.2 years | 7.0 years | – | HA20 | ||
4 | Family 2 | F | 8.3 years | 6.9 years | JIA, CTD-ILD MAS | HA20 | Prednisolone CSA Diclofenac Sodium | Prednisolone CSA Diclofenac Sodium Etanercept |